Several reports have described the involvement of the CCL2/CCR2 axis in the final common pathway in animal models of diabetic kidney disease, and inhibitors of the CCL2/CCR2 axis were effective in ameliorating CKD conditions in these models (Kang et al. 2010; Sayyed et al. 2011). Here, CCR2 is linked to diabetic kidney disease.